The Senate continues to work on changes to the House passed reconciliation bill with their looming July 4th deadline. Joining us right now with the latest is Senator Shelley Moore Capo. She is the Republican Policy Committee chair.And um Senator, thank you for being with us. Let's talk a little bit about where things stand because we we've heard from many of your colleagues who have had issues with this bill as it stands and want to change things. What what's the latest.Well, we always knew when the House p ...

Speaker Mike Johnson says Republicans are on track to pass President uh Trump's tax and spending bill by a July 4th deadline, but the House and Senate are still facing challenges over potential changes to the bill. Join us now, former House Speaker Kevin McCarthy. Uh he's the uh he's the chairman of the Alpha Institute.Walked in here whistling with so I mean he's in such a good mood. It's like he's always happy. Come on.Great to be an American years ago. number and and Becky immediately said, "Well, you're ...

Core Viewpoint - UnitedHealth Group's stock has experienced a significant decline of approximately 50% since its peak in Q4 2024, leading to negative sentiment among shareholders [1] Group 1: Temporary Challenges - Most of the issues faced by UnitedHealth Group are expected to be temporary, including the aftermath of a cyberattack in February 2024 that cost over $2 billion [4] - Higher Medicare Advantage costs have led to the suspension of the company's 2025 full-year guidance, but a return to growth is anticipated in 2026 as insurers adjust premiums [5] - The sudden departure of former CEO Andrew Witty coincided with the withdrawal of the 2025 outlook, but investor concerns were alleviated with the return of Stephen Hemsley, who previously led the company during a period of significant stock growth [6] Group 2: Threat Assessment - The two main threats to UnitedHealth Group, a potential DOJ investigation for Medicare fraud and President Trump's goal to eliminate pharmacy benefits managers (PBMs), are viewed as uncertain [8] - The DOJ investigation is described as "alleged," with the company stating it has not been notified of any such investigation [9] - The removal of PBMs from the healthcare system is seen as a complex challenge that would require a comprehensive plan and significant legislative support, making it a low-probability threat [11] Group 3: Valuation Perspective - UnitedHealth Group's stock is currently trading at a forward price-to-earnings ratio of approximately 13.3, which is below the S&P 500 healthcare sector average of 16.6 and represents the lowest valuation for the company in over a decade [12] - The stock has shown a relatively stable trading pattern since the steep decline in April and May, suggesting that the share price may have bottomed out [13] - Positive developments, such as new full-year guidance, could serve as catalysts for the stock, making it an opportune time for investment [14]

The good news? You don’t have to wait for a promotion or a job change to evolve. Here’s how to stay relevant and reignite your professional momentum right where you are. https://t.co/sKmvK2AZBS https://t.co/DymRHpxMoK ...

These families told me they're leaving the US because of its anti-transgender climate. This is Brandon and Candace. Just 13 days after Trump's inauguration, the medical team for their 9-year-old transgender daughter, Chase, told them that it could no longer provide her with transition related medical care.This Trump executive order stopped research and education grants from going to hospitals that provide such care to minors under 19 years old. Even though Colorado has a shield law meant to protect trans he ...

Um, null, welcome to you. Glad you're here. I'd like to get your initial reaction to this decision by RFK Jr.. Were you surprised the entire panel was eliminated? I was. It was a bit shocking. None of us had any idea that something like this would happen. We were all worried that some administrative snafu would bring a couple people down, but we were none of us were anticipating this kind of an action. And the reaction when it happened among I'm sure you've talked with your colleagues. What did you say amon ...

BrightSpring Health Services (BTSG) FY 2025 Conference June 11, 2025 02:40 PM ET Speaker0 Wanted to start, you just joined as CFO. You've been with the company a long time, but just as you get to know the investor community, just wanted to give you a chance to talk about your background and what you bring to the CFO seat that's new and helps the strategy of the company going forward. Speaker1 Sure. Thank you. I've been with the company for over eight and a half years, have been a part of everything that we' ...

Nano-X Imaging (NNOX) Conference June 11, 2025 01:45 PM ET Speaker0 Welcome to submit questions using the Zoom Q and A interface at the bottom of your screen. After the presentation, we'll open to your questions. And with that, Ron, I'll turn it over to you. Speaker1 You, Alex, and good afternoon for everyone. Before we'll get started, I would like to remind everyone that I'll be making statements during this presentation that may be deemed forward looking statements regarding our activities, commercializat ...

Core Insights - Teladoc Health, Inc. is actively participating in the Goldman Sachs 46th Annual Global Healthcare Conference, indicating its commitment to engaging with investors and stakeholders in the healthcare sector [1]. Group 1: Company Overview - The CEO, Charles Divita, recently celebrated his one-year anniversary in the role, expressing excitement about the potential of virtual care to address healthcare challenges [4]. - Divita highlighted the positive aspects of the company, including its assets, talent level, and market position, which exceeded his expectations upon joining [4]. - The CEO also acknowledged the need for changes and the identification of opportunities and challenges that the company must address moving forward [4].

Prestige Consumer Healthcare (PBH) FY Conference June 11, 2025 10:30 AM ET Speaker0 Good morning, everyone, and thank you for joining us at Oppenheimer's twenty fifth Annual Consumer Growth and Ecommerce Conference. My name is Rupesh Parikh. I'm the senior food, grocery, and consumer products analyst here at Oppenheimer. I'm happy to introduce our next presenting company, Prestige Consumer Healthcare. Joining us today are CEO, Ron Lombardi and VP, IR, and Treasury, Phil Turpolili. Prestige sells and distrib ...